Obi Pharma, Inc.
Records under this name other than the patents Obi Pharma, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 23 patents it holds.
Showing 1 to 5 of 5 · Back to Obi Pharma, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,538,592 | Antibodies, Binding Fragments, and Methods of Use Formerly held In force · High confidence | In force | High confidence | |
| US 12,440,543 | Botulinum Toxin Type a Complex, and Formulation Thereof and Usage Method Therefor Formerly held In force · High confidence | In force | High confidence | |
| US 12,234,266 | CRM197 protein expression Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 9,902,779 | Antibodies, Pharmaceutical Compositions and Uses Thereof Lapsed on the fee record Ended Feb 27, 2026 · High confidence | Lapsed on the fee record | Ended Feb 27, 2026 | High confidence |
| US 11,236,154 | Novel Carbohydrate Antibodies, Pharmaceutical Compositions and Uses Thereof Lapsed on the fee record Ended Feb 1, 2026 · High confidence | Lapsed on the fee record | Ended Feb 1, 2026 | High confidence |